Camille brings 7 years of experience at Sanofi, where she led global and affiliate-level strategies in health economics and outcomes research, notably in rare diseases, working from Boston and Paris. She developed value frameworks, engaged with regulatory agencies (EMA, FDA), and drove real-world evidence initiatives to support product positioning and access. At Cilcare, Camille leads the company’s Evidence, Value & Access strategy, aligning early regulatory planning, market access, and health economics to support innovation in hearing disorders. With a strong strategic mindset and excellent analytical skills, she works effectively across teams to integrate payer-relevant outcomes into clinical development, anticipate reimbursement challenges, and demonstrate value to healthcare stakeholders throughout the product lifecycle.